The 2018 ICM/MSIS classification system was used to assess PJI diagnosis in immunocompromised vs. non-immunocompromised patient populations to determine applicability of the scoring criteria.
Zakko P, Baker EA, Huber CM, Gehrke C, Friedman BJ, Flierl MA. Diagnosing total joint arthoplasty-associated periprosthetic joint infections in immunocompromised patient populations. Poster presented at: American Academy of Orthopaedic Surgeons. 2021 Annual Meeting. 2021 Aug 29- Sep 3; San Diego, CA.